VIVUS (NASDAQ:VVUS)
8.42
+0.08 (0.96%)
| VIVUS (NASDAQ:VVUS) Delayed : | |||||
|---|---|---|---|---|---|
| Previous Close | $8.34 | 52 Week High | $12.88 | ||
| Open | $8.30 | 52 Week Low | $2.72 | ||
| Day High | $8.54 | P/E | N/A | ||
| Day Low | $8.10 | EPS | $-0.70 | ||
| Volume | 4,261,803 | ||||
| More VVUS Info: Chart SEC Filings Profile Historical Options | |||||
What is this?Friends, Peers and Foes
| Ticker | # Stories | Ticker | # Stories |
|---|---|---|---|
| ISTA | 3 | CRL | 2 |
| HITK | 2 | FSP | 2 |
| BGCP | 2 | MXWL | 2 |
| BGFV | 2 | PACR | 2 |
| MYGN | 2 | ANH | 2 |
| BIO | 2 | HIG | 2 |
Entities who have mentioned VVUS
- Merriman Curhan Ford | View Related Stories »
- StreetInsider.com Morning Movers | View Related Stories »
- After-Hours Movers | View Related Stories »
- Life, Style and Real Estate | View Related Stories »
- Stock Buyback | View Related Stories »
- Dividend | View Related Stories »
- Citi | View Related Stories »
- Barclays | View Related Stories »
- JPMorgan | View Related Stories »
- UBS | View Related Stories »
- Canaccord Adams | View Related Stories »
- Wachovia | View Related Stories »
- Credit Suisse | View Related Stories »
- Trading Radar | View Related Stories »
- 13G | View Related Stories »
- Wilbur Ross | View Related Stories »
- Lazard | View Related Stories »
- The Carlyle Group | View Related Stories »
- Twitter | View Related Stories »
- Piper Jaffray | View Related Stories »
- Cantor Fitzgerald | View Related Stories »
- Unusual 11 Mid-Day Movers | View Related Stories »
- Kohlberg Kravis Roberts | View Related Stories »
- Matrix USA | View Related Stories »
- Friedman, Billings, Ramsey | View Related Stories »
View All Major News StreetInsider.com Major News for VVUS
- Vivus (VVUS) Posts Q3 Loss of $0.30, Tops by 1c
- VIVUS (VVUS) Said EQUIP and CONQUER Studies Met All Primary Endpoints
- VIVUS (VVUS) Reports Better-Than-Expected Q2 Loss of $0.19
View All ReportsStreetInsider.com Reports on VVUS
- Vivus (VVUS) December volatility elevated at 102 into positive ED results
- VIVUS, Inc. (VVUS) Reports Positive Phase 3 Study of REVIVE
- After-Hours Movers 11/17: LDK, VVUS Higher; ADSK, BWS, CNQR, TEN, EMS, DRYS Lower
- VIVUS (VVUS) Will Announces Phase 3 Results of Avanafil Before The Market Opens
- After-Hours Movers 11/03: QLTY, PACR, BGCP, TESO Higher; STEC, TRLG, CLRT, CRL, MYGN Lower
View All Press ReleasesCompany Press Releases on VVUS
- Trading Review for Vivus Inc. Issued by Beacon Equity
- VIVUS Announces Positive Results From Phase 3 Study of Avanafil in Erectile Dysfunction; Data Demonstrate Robust Efficacy, Favorable Side-Effect Profile
- VIVUS to Host Conference Call and Webcast Discussion of Avanafil Phase 3 Results
- VIVUS to Present at Lazard Capital Markets Healthcare Conference
- VIVUS To Present at Merriman Curhan Ford's Investor Summit
StreetInsider Reports on VVUS by Category
View All BlogsBlogs on VVUS
- Diabetes Care: Global Investing Opportunities
- CTT's Pain Mangement Device Sales to Result in Positive Surprise in 10Q
- Wednesday Options Recap
- Closing Bell: An almost recovery (AMD, AXP, DRYS, ETFC, FTNT, VVUS)
- Wall Street Breakfast: Must-Know News
View All FilingsSEC Filings on VVUS
- Form 8-K VIVUS INC For: Nov 18
- Form 8-K VIVUS INC For: Nov 17
- Form 8-K VIVUS INC For: Nov 11
- Form 4 VIVUS INC For: Nov 05 Filed by: LOGAN MARK B
- Form 8-K VIVUS INC For: Nov 03
Comments on recent VVUS articles
Comments on VVUS
No comments are currently available.
on Nov 13, 2009
at 03:55 PM ANDREW OLIVER SATCHELL EXCELLENT
Article: Trading Radar for 11/03: UBS (UBS), Yamana Gold (AUY), Archer-Daniels (ADM), Royal Caribbean (RCL), Marathon (MRO) Report